A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:November 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:November 1, 2021Completed
Condition(s):TuberculosisLast Updated:November 11, 2021Terminated
Condition(s):Tuberculosis, Pulmonary; Tuberculosis, Multidrug Resistant; Extensively Drug-Resistant TuberculosisLast Updated:December 1, 2021Completed
Condition(s):Multidrug Resistant TuberculosisLast Updated:November 23, 2020Completed
Condition(s):Pulmonary TuberculosisLast Updated:March 7, 2007Completed
Condition(s):Multidrug-resistant TuberculosisLast Updated:May 15, 2019Completed
Condition(s):Multidrug Resistant TuberculosisLast Updated:July 7, 2022Active, not recruiting
Condition(s):Tuberculosis; HIV InfectionsLast Updated:September 21, 2023Recruiting
Condition(s):Pulmonary TBLast Updated:January 5, 2024Active, not recruiting
Condition(s):Tuberculosis; HIV InfectionsLast Updated:January 27, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.